Cargando…
TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Although considerable advances in CRC treatment have been achieved, effective treatment improvement has hit a bottleneck. This study demonstrated that TYRO3 expression was aberrantly increased in CRC tissues with prognosis ass...
Autores principales: | Shao, Xinyu, Sun, Yibin, Zhong, Kaiqiang, Gu, Jinrong, Yu, Yang, Hu, Tong, Kuai, Xiaoyi, Xing, Yechen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188355/ https://www.ncbi.nlm.nih.gov/pubmed/37116196 http://dx.doi.org/10.18632/aging.204656 |
Ejemplares similares
-
High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism
por: Shao, Xinyu, et al.
Publicado: (2023) -
Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review)
por: Škovierová, Henrieta, et al.
Publicado: (2018) -
TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
por: Schmitz, Robin, et al.
Publicado: (2016) -
Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesis
por: Chen, Hsiao-Fan, et al.
Publicado: (2016) -
Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis
por: Shao, Peng, et al.
Publicado: (2017)